These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14712548)

  • 41. Appraising boardroom performance.
    Conger JA; Finegold D; Lawler EE
    Harv Bus Rev; 1998; 76(1):136-48. PubMed ID: 10176916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Managing CEO transition.
    Gardner JR
    Trustee; 2005; 58(10):33. PubMed ID: 16382734
    [No Abstract]   [Full Text] [Related]  

  • 43. Information technology and the board of directors.
    Nolan R; McFarlan FW
    Harv Bus Rev; 2005 Oct; 83(10):96-106, 157. PubMed ID: 16250628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lift outs: how to acquire a high-functioning team.
    Groysberg B; Abrahams R
    Harv Bus Rev; 2006 Dec; 84(12):133-40, 164. PubMed ID: 17183798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Right away and all at once: how we saved Continental.
    Brenneman G
    Harv Bus Rev; 1998; 76(5):162-4, 166, 168 passim. PubMed ID: 10185430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix management: not a structure, a frame of mind.
    Barlett CA; Ghoshal S
    Harv Bus Rev; 1990; 68(4):138-45. PubMed ID: 10106795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The case of the combative CFO.
    Nichols NA; Bagley CE; Beard E; Dworkin D; Millstein IM
    Harv Bus Rev; 1992; 70(4):14-6, 20-1, 24. PubMed ID: 10119718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The ambidextrous organization.
    O'Reilly CA; Tushman ML
    Harv Bus Rev; 2004 Apr; 82(4):74-81, 140. PubMed ID: 15077368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Divestiture: strategy's missing link.
    Dranikoff L; Koller T; Schneider A
    Harv Bus Rev; 2002 May; 80(5):74-83, 133. PubMed ID: 12024760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integration managers: special leaders for special times.
    Ashkenas RN; Francis SC
    Harv Bus Rev; 2000; 78(6):108-16. PubMed ID: 11184965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1992 corporate profiles.
    Provider; 1992 May; 18(5):67-99. PubMed ID: 10117804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Women as a business imperative.
    Schwartz FN
    Harv Bus Rev; 1992; 70(2):105-13. PubMed ID: 10117366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Six Sigma pricing.
    Sodhi MS; Sodhi NS
    Harv Bus Rev; 2005 May; 83(5):135-42, 154. PubMed ID: 15929409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The case of the machinists' mutiny.
    Chew WB
    Harv Bus Rev; 1990; 68(6):14-7, 20, 24 passim. PubMed ID: 10107958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How much cash does your company need?
    Passov R
    Harv Bus Rev; 2003 Nov; 81(11):119-22, 124-6, 128, 140. PubMed ID: 14619157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How you slice it: smarter segmentation for your sales force.
    Waaser E; Dahneke M; Pekkarinen M; Weissel M
    Harv Bus Rev; 2004 Mar; 82(3):105-11, 128. PubMed ID: 15029794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Succession and failure.
    Cespedes FV; Galford RM
    Harv Bus Rev; 2004 Jun; 82(6):31-5; discussion 36-8, 40, 42, 135. PubMed ID: 15202285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surviving your new CEO.
    Coyne KP; Coyne EJ
    Harv Bus Rev; 2007 May; 85(5):62-9, 142. PubMed ID: 17494251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Giving mergers a head start.
    Croyle R; Kager P
    Harv Bus Rev; 2002 Oct; 80(10):20-1, 126. PubMed ID: 12389456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rebuilding the R&D engine in big pharma.
    Garnier JP
    Harv Bus Rev; 2008 May; 86(5):68-70, 72-6, 128. PubMed ID: 18543809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.